 |
(2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione) |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| USA Market Approval | USA |
| USA Designation Date | 2015-10-14 00:00:00 |
| Sponsor | Genkyotex Innovation SAS;18 Avenue Marie Curie;Archamps |
